NCT04619433 2025-09-23A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.Jiangsu HengRui Medicine Co., Ltd.Phase 3 Terminated48 enrolled
NCT05849246 2024-08-20The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)Innovent Biologics (Suzhou) Co. Ltd.Phase 2 Terminated4 enrolled